AI can augment oncology nursing through symptom triage support, trial matching, care plan personalization, pharmacogenomics ...

Learn the risk factors, symptoms and screening options tied to colorectal cancer as cases continue rising among younger ...

Ongoing annual imaging of the remaining breast, plus peer navigation and patient self-advocacy, are framed as practical ...

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

Some patients treated with immunotherapy may develop lifelong endocrine conditions requiring ongoing hormone replacement, ...

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith.

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

Neoadjuvant Enhertu→THP improved pCR to 67.3% vs 56.3% with AC→THP in stage II–III high-risk HER2-positive disease (DESTINY-Breast11). Adjuvant Enhertu achieved 3-year IDFS 92.4% vs 83.7% with T-DM1 ...

FDA approved adjuvant atezolizumab for post-cystectomy MIBC with ctDNA MRD positivity, alongside Signatera CDx as the required companion diagnostic for eligibility determination. IMvigor011 randomized ...

Michele Kranz, discussed how oncology nurse navigators like herself support patients with cancer through education, advocacy and care coordination. Patients with cancer often face a complex care ...

A 15-patient, single-institution pilot longitudinally paired symptom surveys and stool profiling from baseline to 12 weeks after ICI initiation to explore microbiome–symptom associations. Fatigue ...

Prior fatalism led to missed opportunities for earlier veterinary evaluation when subtle signs preceded an ultimately terminal pet cancer. Post-treatment empathy increased willingness to authorize ...